United Therapeutics Corp (NASDAQ:UTHR) - Overview

Stock Report

United Therapeutics Corp UTHR

Last Price
$129.37

Day Change
2.88|2.28%

As of 05/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close126.49
Day Range127.28 - 131.13
Mkt Cap5.49Bil
52-Wk Range97.52 - 164.04
Yield %-
ISINUS91307C1027
Volume506,009
P/E8.68
P/S3.89
P/CF12.26

Share Price

Financials
201320142015
More ...
Income Statement
Revenue1,116.981,288.521,465.76
Operating Income292.50538.80699.02
Net Income174.56340.07651.64
Basic EPS3.497.0614.17
Avg. Diluted Shares Outstanding535451
Balance Sheet
Current Assets909.01974.201,275.34
Non Current Assets1,178.55910.21909.11
Total Assets2,087.571,884.412,184.45
Current Liabilities687.67504.31440.82
Total Liabilities828.29642.05595.89
Total Equity1,259.271,242.361,588.55
Cash Flow
Operating Cash Flow425.27355.26382.76
Capital Expenditure-31.91-47.44-49.79
Free Cash Flow393.36307.82332.97

In millions, except "Basic EPS". Currency is USD.

Company Profile

United Therapeutics Corp is a biotechnology company. The Company is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Value

Fiscal Year Ends

December

Employees

750
Key Stats
More ...
Price/Earning TTM7.94
Price/Book2.92
Price/Sales TTM3.93
Rev Growth (3 year avg)16.96
EPS Growth (3 year avg)-
Operating Margin % TTM47.69
Net Margin % TTM44.46
ROE TTM46.04
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.